French

This guide, for radio practitioners, health workers, and donors, discusses the use of radio to promote the prevention of HIV/AIDS in developing countries. The guide discusses the following issues in using radio as a health communications tool: conducting initial research and needs assessment; selecting appropriate materials; pre-testing programs; scheduling programs; developing an HIV/AIDS campaign; building partnerships with media and other organizations; monitoring and evaluating radio programs; and working towards sustainable and effective HIV/AIDS radio broadcasting.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

This monograph focuses on HIV/AIDS projects and programs that have improved quality of life for people living with or affected by HIV. These initiatives are widely spread geographically, and they include programs in Cambodia, the Ivory Coast, Ecuador, India, Kenya, South Africa, and two regions of Uganda. The monograph describes these projects and programs, summarizes the main lessons learned through them, and examines their commonalities and differences.

This policy paper discusses "debt swaps" as a way of funding the expansion of HIV/AIDS programs for countries that have problems paying or are unable to pay their external debt. The paper presents definitions and categories of swaps such as debt-for-equity swaps, debt buy-backs, debt-for-nature swaps, and debt-for- development swaps. It also discusses advantages and disadvantages of debt swaps, and provides information on the use of debt swaps by low-income countries severely affected by HIV/AIDS in order to scale up their HIV/AIDS programs.

This pamphlet discusses the risk of exposure to HIV during emergency situations such as war, civil strife, disasters or epidemics, since many of the conditions that facilitate the spread of HIV are present in emergencies.

This poster was designed educate members of the Navajo Nation about the conditions that put one at risk for TB.

This report presents guidelines for assessing quality, improvement, and accreditation in caring for persons with HIV. The report explains the rationale behind establishing guidelines, their uses, the purpose of accreditation, and the key principles of the accreditation framework. It lists the major categories of standards for HIV care, describes how the model standards were selected, and explains how to begin using the standards in an HIV care site or organization. The minimum set of standards to initiate antiretroviral therapy (ART) and proposed standards are provided.

This report describes the progress toward “3 by 5,” the target that 3 million persons with in developing and transitional countries would be receiving antiretroviral treatment (ART) by 2005. The report discusses global efforts to increase access to ART and the reasons for the successes and failures. It highlights the progress and challenges in some countries and obstacles to scaling up ART and HIV prevention.

This pamphlet for persons diagnosed with TB or multidrug-resistant TB (MDR TB) contains practical advice, suggestions, guidance, and information to help the patient cope with the illness. The tips are based on personal experience of other TB patients and common sense. Tips cover an explanation of the disease its symptoms, treatment including Direct Observed Therapy (DOTS), taking medication and medication for children, side effects, managing time in isolation, communication with others while in isolation, regaining control of one’s life, eating healthy, and after completing treatment.

This report is a manual on antiretroviral treatment and care of HIV infected patients in African settings. This second version of the manual was written by a team of doctors and researchers in France. It provides concise updated information on types of antiretroviral drugs, post-exposure prophylaxis, treatment recommendations, infant formulations, generics, and treatment of opportunistic infections.